- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- CVS Caremark to stop selling tobacco in all store locations
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
TORONTO — Retail pharmacy network Katz Group Canada has appointed Frank Scorpiniti as COO.
With more than 20 years of retail pharmacy experience, Scorpiniti previously was SVP pharmacy operations at Duane Reade. Prior to Duane Reade, he held positions of increasing responsibility at Longs Drug Stores.
“Frank is a strategic thinker who has a passion for the retail pharmacy industry, and a proven ability to drive growth and performance within an organization,” stated Andy Giancamilli, CEO of Katz Group Canada. “We are confident that Frank’s leadership and experience will help enhance the customer experience across our network of corporate, franchise and banner pharmacies.”
The company also announced the appointment of Warren Jeffery as chief development officer, which Jeffery will assume in addition to his current role as interim chief merchandising officer. Reporting to Giancamilli, Jeffery will lead the company’s productivity and growth initiatives.
Katz Group Canada’s retail pharmacy network encompasses more than 1,800 chain, franchise and independent pharmacies across the country. Pharmacy banners include Rexall, Rexall Pharma Plus, The Medicine Shoppe, Guardian and I.D.A. Katz Group’s holdings also include Rexall Specialty Pharmacy, Rexall Direct, Rexall Health Services and ProPharm Limited.